Monthly Prescribing Reference

Trogarzo Label Updated With 90-Second IV Push Loading Dose

The new approval allows for the 2000mg loading dose to be administered as an IV push rather than a 30-minute IV infusion. The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated ...
Monthly Prescribing Reference

New Trogarzo Administration Method Cuts Maintenance Dose Time for HIV Patients

The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks. The Food and Drug Administration (FDA) has approved Trogarzo ® ...
Business Insider

Theratechnologies Receives FDA Approval For Intravenous Push Administration Of Trogarzo

(RTTNews) - Theratechnologies Inc. (THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received FDA approval for the intravenous push mode ...
Medscape

FDA Approves HIV-1 Treatment Ibalizumab for 30-Second IV Push

The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for administration by intravenous push. Ibalizumab-uiyk, a long-acting ...
Nasdaq

Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, ...
Nature

Intravenous Infusion Systems and Flow Rate Management

Intravenous infusion systems are a cornerstone of modern clinical care, ensuring that fluids and medications are administered at precise rates to meet patient needs. These systems are integral to a ...